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ABSTRACT
The drug delivery system has been advanced to release the drug according to the body requirement during the entire period of treatment and also 
for the delivery at the targeted site. Several novel drug delivery systems have emerged encompassing different route of administration to achieve 
controlled and targeted drug delivery, magnetic microsphere carrier being one of them. Magnetic microsphere is an alternative to traditional radiation 
methods. As the traditional radiation methods use highly penetrating radiation that is absorbed throughout the body and cause side effects hence its 
use is limited. Therefore, a safe and effective alternate is needed like magnetic microsphere. The excessive circulating drug particles are minimized by 
this delivery system. Moreover, the aim of specific targeting is to enhance the effectiveness of drug delivery and at the same time to lessen the toxicity 
and side effects. Magnetic carriers receive magnetic responses to a magnetic field from incorporated materials that are used for magnetic microsphere 
are chitosan, dextran, etc. One of the most utilized magnetic microspheres is serum albumine whether from human or other suitable animals. Drug 
release from the albumin microsphere can be controlled by various stabilization procedures. Overall, the targeted magnetic microsphere is much 
valuable novel drug delivery system for what more work have to be done. By knowing the importance of all this, the present paper reviews the 
mechanism, preparation, and applications of magnetic microspheres. As the targeted drug delivery system implies selective and effective localization 
of drug into the target at therapeutic concentrations with limited access to non-target sites. Magnetic microspheres hold great promises for reaching 
the goal of controlled and site-specific drug delivery.
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INTRODUCTION
Extensive labors have been dedicated in recent years to utilize potential 
pharmaceutical devices like novel drug delivery systems. Design and 
development of novel drug delivery system have two basics. First, it 
should distribute the drug in accordance with a predetermined rate, and 
second, it should release therapeutically effective quantity of drug at the 
site of action [1,2]. Conventional drug delivery undergoes from several 
drawbacks such as increased variation in the circulatory drug level, extra 
frequency of dosage administration, increased gastrointestinal irritation, 
and dose-related side effects. To solve these disadvantages, controlled 
release drug delivery systems have been planned for even and constant 
drug release over a prolonged period [3]. The steady drug release is 
achieved by use of different kinds of polymeric systems; biodegradable 
polymer microspheres are one of the most common types which are used 
as a targeted drug delivery systems. Microspheres can encapsulate many 
types of drugs with small molecules, proteins, and nucleic acids are easily 
administered through a syringe needle. They are normally biocompatible, 
can give high bioavailability, and are capable of constant release for long 
periods [4]. Magnetite offers a large potential for innovation in electronics, 
optoelectronics, magnetic storage, biomedical, Ferrofluid, separation, 
and magnetically guided drug carriers for targeting the therapy [5].
Magnetic microsphere is small particle, with diameter in the micrometer 
range (1-1000 µm). Magnetic microsphere is occasionally referred 
to as microparticles. Magnetic polymer microspheres are generally 
composed of magnetic cores to make sure for strong magnetic response 
and polymeric shells to give positive functional groups and protect from 
particle aggregation [6]. Small amounts of drug targeted magnetically 
to restricted sites can replace large doses of drug that, using traditional 
administration methods, freely flow in the blood and beat the target 
site in a generalized way only. Moreover, drugs within the sphere 
are protected from breaking down during transport. Such drugs are 
targeted instead of distributed in blood and do not harm sensitive 
organs such as bone marrow. Magnetic microspheres are a substitute 
to traditional radiation methods which use extremely penetrating 
radiation that is absorbed throughout the body. Its use is limited by 
toxicity and side effects. Magnetic radioactive microspheres are applied 
in a way similar to non-radioactive spheres. A magnet, placed outside 
the body, is directed to the target site. The magnet can be a rod-shaped 
permanent magnet of any size or can be contained in equipment that 
looks like an open magnetic resonance imaging scanner. The loaded 
microspheres are introduced into a blood vessel and in as little as half 
an hour; they get collected at the target site to emit radiation which kills 
surrounding cancer cells. The remedial action is achieved usually in a 
couple of days or weeks depending on the material used. The treatment 
can be repeated if required. Spheres are prepared with microscopic 
magnetic particles, such as iron [5,6], so these particles can be retained 
at the target site by the application of an external magnetic field of 
suitable strength. Magnetic fields are supposed to be safe to biological 
systems and adaptable to any part of the body.
PRINCIPLES OF MAGNETIC DRUG TARGETING
The principle of this treatment shows that the magnetic drug can be 
retained at or made to flow toward the target site by the application 
of an external magnetic field. Retention of magnetic carrier at target 
site will decrease reticuloendothelial clearance and increase site 
specificity [7].
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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HOW THE MAGNETIC MICROSPHERE WILL TARGET
The major difficulty of cancer remedy is not the lack of better drug, 
but that such medicines are very difficult to concentrate in the tumor 
tissue without leading the toxic effect on normal nearby tissue or 
organs. Magnetic drug delivery by particular carriers is an efficient way 
of delivering a drug to a localized disease site. A drug or therapeutic 
radioisotope is encapsulated in a magneticakes place within area, to 
which the magnetic field is applied. The gathering of the carrier at 
the target site allows them to deliver the drug locally. Effectiveness 
of gathering of magnetic carrier on physiological carrier depends 
on physiological parameters, for example, particle size, surface 
characteristic, field strength, and blood flow rate. The magnetic 
field helps to flow the magnetic carrier into the targeted area. Large 
concentration of chemotherapeutic agents gets collected near the 
target site without any toxic effect to normal neighboring tissue or to 
whole body. It is possible to replace large amounts of drug targeted 
magnetically to localized disease site, reaching effective and up to 
several fold increased drug levels [8].
Magnetite (Fe3O4)
Magnetic particles consist of one or more magnetic cores with a 
coating matrix of polymers, silica or hydroxylapatite with terminal 
functionalized groups. The magnetic core generally consists of 
magnetite. Magnetite is magnetic oxide of iron and is a blend of the 
two oxides, FeO and Fe2O3. It is also referred to as ferrous ferrite. It 
gives magnetic property just like pure iron and exists in the form 
of fine particles and has been used for various application in vivo 
like in transmission radiography, as contrast gastrointestinal agent, 
for inducing clotting in arteriovenous malformation, as a tracer of 
blood flow and in radionuclide angiography. Iron particles with small 
diameter can pass through small capillaries in the body [7].
Preparation of magnetite from a-FeOOH (goethite) or FeO
Here, the researchers flushed nitrogen gas through double-necked 
round-bottom flask (500 ml) fitted with a condenser. Then, they charge 
the flask with 8.9 g (0.1 mol) of FeO, 9.94 g (0.05 mol) of FeCl2.4H2O 
along with 250 ml deionized water and then 50 ml of 2M NaOH was 
added. After refluxing reaction mixture for 12 hrs and during the 
transformation of the pH, its pH fell from 14 (orange) into 8-9 (black 
precipitates) particles were washed with distilled water, filtered and 
dried under vacuum at room temperature [9,10].
SELECTION OF DRUGS FOR THE PREPARATION OF MAGNETIC 
MICROSPHERES
The drug to be selected should be less dangerous, inexpensive because 
waste rate for it is 99.9% [11].
Specific examples of drugs are as follows:
Adriamycin, amphotericin B, membrane active agents, prostaglandins, 
and immunosuppressive agents [12].
METHODS OF PREPARATION OF MAGNETIC MICROSPHERES
Continuous solvent evaporation
Polymer encapsulated microspheres are synthesized on the basis of a 
continuous solvent evaporation technique. A solution of polymer, drug, 
and magnetite should be added to the volatile organic solvent, which 
forms auxiliary solution on stirring. The resulting solution should be 
maintained at temperature of 22-30°C. The suspension of magnetic 
microspheres is formed and should be separated by centrifugation. The 
product is freeze-dried and stored at 4°C [13].
Phase separation emulsion polymerization
The briefly aqueous solution of polymer, drug, and magnetite is added 
to the vegetable oil and emulsified using emulsifying agent. Stir 
this solution using magnetic stirrer at 1,500 rpm for 2 minutes. The 
resultant is stabilized by heating at 100-150°C. Cross-linking agent is 
injected dropwise into the resultant emulsion by continuous stirring. 
The magnetic microspheres should form in the oil suspension and then 
separated from oil by washing procedures. The product is needed to 
freeze-dried and stored at 4°C [14].
Multiple emulsion method
In this method, the researchers added water dispersible magnetite with 
a poly(acrylic acid)–poly(ethylene glycol) (PEG/PAA) coating added to 
the bovine serum albumin (BSA) containing inner water phase. 0.2 ml 
of a 1 mg/ml BSA solution added to a 4 ml mixture of dichloromethane 
and EA at a ratio of 3-1 containing 200 mg of poly(lactic-co-glycolic 
acid) (first w/o emulsion has been prepared using a suitable 
homogenizer in an ice bath at 26,000 rpm for 2.5 minutes). Then, 
15 ml of a 1% poly(vinyl alcohol) (PVA) solution poured directly 
into the primary emulsion and re-emulsified using the similar 
homogenizer under the similar conditions for 2.5 minutes. Then, the 
W/o/w emulsion immediately poured into a beaker containing 85 ml 
of 1% PVA solution and stirred in a hood under an overhead propeller 
for 2 hrs, allowing the solvent to evaporate. Solidified microspheres 
harvested by centrifugation at 2500 rpm for 10 minutes and washed 
with distilled water 3 times [15].
Preparation of blank P(styrene-itaconic acid-divinylbenzene) 
(St-IA-DVB) microsphere
The inverse phase suspension polymerization method has been 
employed to prepare microspheres. The reaction has performed in a 
250 ml three-neck flask fitted with a mechanical stirrer. The continuous 
phase comprised 100 ml of castor oil and 10 ml of span 80. Then, a 
determined amount of IA, St, DVB, and BIS were dissolved completely 
in dimethyl sulfoxide, and the organic phase was added drop wisely 
into the flask, with 70°C heating using an oil bath. Then, the initiator 
of ammonium persulfate was added drop wisely with syringe. The 
reaction was continued for 8 hrs with continuous stirring. The resulting 
microspheres were separated by centrifugation. The centrifuged 
microspheres were washed firstly with diethyl ether, followed by 
deionized water at least three times. After 3 times purification, the 
microspheres were lyophilized.
Preparation of magnetic nanoparticles coated P (St-IA-DVB) 
microspheres (MNPSID microspheres)
For this, the researchers took 10 mg of blank microspheres and dispersed 
in 50 ml deionized water with continuous stirring. To this, they added 
50 µl of Fe3O4 nanoparticles drop wisely in 2 ml deionized water with 
ultrasonic dispersion. After blending and dispersing completely in 
the water was done. The reaction kept up for 4 hrs, and the product 
was washed with excess deionized water 3 times and centrifuged. The 
obtained MNPSID microspheres were freeze dried and then kept in 4°C 
before use [16].
Cross-linking method
Here, the following reagent is used as follows:
Reagents used: Acetate buffer used as solvent for the chitosan polymer; 
cross-linker: Glutaraldehyde Used as medium: Sodium hydroxide 
solution synthesis of magnetic fluid: A 35% (w/v) ferrous sulfate 
solution, 54% (w/v) ferric chloride solution and 36% (w/v) sodium 
hydroxide solution were prepared using distilled water.
Then, the ferric salt and ferrous salt were mixed, stirred, and heated. 
The alkaline solution was added when the temperature reached 55°C. 
The mixture was stirred for 30 minutes, and then 5 g of PEG-10000 
was added. The temperature was raised to 80°C and maintained for 
30 minutes. The mixture was then neutralized while cooling, and the 
magnetic fluid was prepared. 1% (w/w) chitosan was dissolved in 
acetate buffer at pH 4.5. The dissolved chitosan was added dropwise 
on the magnetic fluid. Formed chitosan magnetic microspheres 
were washed with deionized water and soaked in 1, 3, and 5 mol % 
glutaraldehyde solution for 2 hrs and then washed with deionized 
water [17].
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Swelling and penetration method
For swelling of polymer microparticles, researchers mixed 
0.25 g of PS (Micron-size polystyrene) particles with 35 mL of a 
N-methyl- 2-pyrrolidone (NMP)/water solution in a specific v/v 
NMP - to-water ratio. In later preparations of magnetic microspheres, 
they added sodium dodecyl sulfate (SDS) to the NMP/water solution. 
Whenever SDS was used, to each NMP/water solution 0.025 g of SDS 
was added. The NMP/water mixture with PS spheres was left soaking 
for 24 hrs at room temperature with stirring. To the mixture of PS 
sphere and NMP/water solution, 2.5 mL of the super paramagnetic 
nanoparticle dispersion (24 mg/mL or other specified concentration) 
was added at 30°C while shaking (at 140 r/minutes) for 1-5 days to 
allow the magnetic nanoparticles to penetrate into the interior of the 
PS particles. After this they separated, the polymer particles from 
the solution by centrifugation. Finally, particles were sequentially 
washed with methanol, deionized water, and dried under vacuum 
at room temperature for 1-2 days to yield the magnetic polymer 
microspheres [18].
Sonochemical method
In this method, the microspheres are having iron oxide-filled and coated 
globular BSA. Here, the magnetic microspheres were prepared from 
BSA and iron penta carbonyl or from BSA and iron acetate. Protein 
microspheres have a number of biomedical application, i.e., use as echo 
contrast agents for sonography. The microsphere was formed by two ways 
(i) either by heat denaturation at various temperatures or (ii) by cross 
linking with carbonyl compounds in the ether phase. Cross linking was 
completed as the microspheres are formed by chemically cross-linking 
cysteine residues of the protein with HO2 radical formed around a non-
aqueous droplet. The chemical cross-linking is known to be responsible 
for the formation of the microspheres. This is due to the chemical ejects 
of the ultrasound radiation on an aqueous medium [19-22].
Storage
Several precautions have to be kept in mind during the formation 
microsphere. These are
1. Microsphere suspensions should not be frozen, as freezing is likely 
to cause irreversible aggregation.
2. Cold storage (2-8°C) is recommended to inhibit microbial growth. 
“Standard” (non-protein coated) microsphere suspensions do not 
contain an antimicrobial agent.
3. All suspensions should be handled using aseptic technique.
4. Continuous rolling (e.g. 3-5 r/minutes on a cell culture roller) 
is recommended to keep microspheres in suspension, without 
generating foam (foam may cause particle loss through bead 
entrapment).
5. If continuous rolling is not possible, particles should be thoroughly 
resuspended before use. Higher speed rolling (30-60 r/minutes for 
2-4 hrs) is effective for the resuspension of settled material.
6. Again, rolling speed is intended to effectively resuspend the beads 
without generation of foam [23].
BIODISTRIBUTION AND TISSUE CONCENTRATION OF 
MICROSPHERES
In physiological solution containing 0.1% (w/v) Tween 80 or a viscosity 
enhancing agent, such as 50% (w/v) dextran, aggregation in target 
vessel can be minimized by injecting microspheres. For spheres smaller 
than 3 µm, initial (5-30 minutes) biodistribution is a function of:
a. The dose relative to the capacity of target capillaries.
b.	 The	degree	 to	which	 the	magnetic	 field	 overlaps	microvessels	
supplied by the injection vessel.
c.	 The	extent	of	venous	shunting	before	microspheres	reach	the	field.
d.	 The	flow	rates	in	target	vessels.
The large doses of trace-labelled spheres (6.6 mg/kg, sufficient to 
produce effective levels of f- met-leu-phe peptide) were infused 
intravenously in to rates over a 3 minutes interval in a study. Here, 
the infusion was allowed to travel at native flow rates into the central 
venous system through the right heart in to bath lungs. The movement 
was captured by a 0.55 T magnetic field (gradient of 0.01 T/mm), which 
enveloped the right thorax and the middle half of the left thorax. In the 
later study, the splenic and renal concentrations of the spheres were 
reported to be slightly higher because of greater vascular shunting due 
to incomplete magnetic envelopment of the left lung.
MAGNETICALLY MODULATED SYSTEMS AND DEVICES
Magnetically modulated polymeric controlled drug delivery systems 
that deliver the drugs at increased rate on demand have been developed 
extensively in recent years. These systems consist of polymeric matrix, 
in which drug powder is discrete. The polymeric matrix consists of 
ethylene vinyl acetate copolymer (EVAc) with some magnetic beads. 
The beads used are either (i) magnetic steel beads composed of iron 
(79%), chromium (17%), carbon (1%), manganese (1%), silicon (1%), 
molybdenum (0.75%), and phosphorus (0.04%) or (ii) small amount 
of samarium cobalt magnets. These systems are formulated by adding 
approximately 50% of drug-polymer mixture to a glass mold, which 
is	cooled	to	−80°C	using	dry	ice,	after	this	the	magnetic	particles,	are	
added followed by the remaining drug-polymer mixture.
In case of in vivo experiment, the magnetic tablets are placed in glass 
vials. An oscillating external magnetic field, which is generated by a 
device that rotates the permanent magnets below the vials, controls the 
release rates.
Mechanism
The release of macromolecules from EVAc systems without magnetic 
beads suggests that molecules with molecular weight >300 cannot 
permeate the polymer. The direct merging of macromolecules in the 
polymer-macromolecule using cast method caused a tortuous and 
compound sequence of pores development in the matrix. The release 
rates are dogged by factors affecting infiltration of water into the 
polymer and drug out of these pores.
Drug release
Traditional methods failed to check drug, due to reduction in circulating 
free drug levels by a factor exceeding 100 when magnetic targeting 
is used (Ranney, 1985). Even the blood levels monitored by some 
possible methods do not give reasons when correlated with tissue 
levels. Estimates of free drug level can be made at dissimilar intervals 
from the concurrent interpretation of the results obtained from 
carrier localization studies in tissue and drug release profile in vitro. 
This method is simple and ignores some factors that influence drug 
release from carrier in vivo like enzymatic digestion of microspheres 
accelerated drug release and retro diffusion of the drug back to 
microvessel enhances drug clearance. The accurate and precise results 
can be obtained by measuring the drug levels of the target site for every 
using magnetic resonance methods [7].
CHARACTERIZATION OF MAGNETIC MICROSPHERES
1. Particle size and size distribution
 The particle size of microsphere has been determined by using an 
optical microscope with the aid of a calibrated ocular micrometer. 
Here, total 100 particles were measured for size and then the 
average of these particles taken as average particle size.
2. Surface characterization
 Surface characterization can be determined by using:
  a. High-resolution microscopy
  b. Scanning electron microscopy (SEM)
  c. Scanning tunneling microscopy
3. Surface charge analysis
 They can be achieved by using:
  a. Micro electrophoresis
  b. Laser Doppler anemometry.
4. Density
a. Tapped density
 It is determined by pouring accurately weighed microspheres in 
measuring cylinder and tapped 100 times from a stable height 
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  True density = weight of powder/tapped volume of powder
b. Bulk density
 It is determined by pouring accurately weighed microspheres 
in measuring cylinder and thus determining its bulk volume.
  Bulk density = weight of powder/bulk volume of powder
5. Flow properties
 Flow properties are measured by following ways:
 a. Angle of repose
   Angle of repose is the angle that a static heap of particles makes 
with	the	horizontal.	The	flow	properties	of	microspheres	can	
be	determined	by	fixed	funnel	flow	method,	which	is	used	to	
calculate angle of repose.
	 	 	 tan	θ	=	h/r
	 	 	 θ	=	tan−1 hr/r
b. Hausner ratio
 It is determined from the ratios of tapped density and bulk density.
  Hausner ratio = tapped density/bulk dendity
6. Hardness
	 Hardness	 is	 defined	 as	 the	 force	 requires	 breaking	 the	










Evaluation of magnetic microspheres
IR spectroscopic studies
The IR spectra of the free drug and the microspheres were reported. 
The matching peaks equivalent to the functional groups and albumin 
(BSA, egg albumin, human serum albumin) features confirm that the 
polymer and the method of preparation has not affected the drug 
stability.
Thin layer chromatographic (TLC) studies
The TLC method has been followed for testing the drug stability in 
prepared microsphere. The Rf values of the prepared microspheres can 
be compared with the Rf value of the pure drug. The values point to the 
drug constancy.
Surface topography by SEM
SEM of the microspheres illustrates the surface morphology of the 
microspheres such as their shape and size.
Particle size distribution of prepared microspheres
The size of the ready microspheres can be measured by the optical 
microscopy way using calibrated stage micrometer for randomly 
selected samples of all the formulations.
Drug entrapment capacity
Effectiveness of drug entrapment for each batch can be calculated in 
terms of percentage drug entrapment as per the following formula:
%	Entrapment	=	(actual	content/theoretical	content)	×100
In vitro release studies
In-vitro release studies can be achieved according to USP type I 
dissolution apparatus at appropriate pH conditions. The temperature 
should be upheld at 37±0.5°C and the rotation speed of 100 rpm. 
Then, 5 ml of sample should be withdrawn at various time intervals 
and restocked with an equal volume of fresh dissolution media. The 
drug content in the sample can be analyzed spectrophotometrically at 
specific wavelength (nm) [25].
In vivo experiments
In vivo study here used, implants containing EVAc embedded magnets 
and bovine zinc insulin. The implants are placed in diabetic rats for 
2 months and blood glucose levels were monitored. The blood glucose 
level decline due to diffusion of insulin from the polymer and when the 
diabetic rat were exposed to an oscillating magnetic field; the blood 
glucose levels were further lowered from 50 to 200 mg/dl below this 
basal level; this is since of magnetic field conditions. The result was 
confirmed by radioimmunoassay.
Advantages of magnetic microspheres
1. Therapeutic responses in target organs at only one-tenth of the free 
drug dose.
2. Controlled drug release in target tissues for intervals of 30 minutes - 
30 hrs, as desired.
3. To avoid acute drug toxicity directed against endothelium and normal 
parenchymal cells.
4. Adaptable to any part of the body.
Disadvantages of magnetic microspheres
1. It is an expensive, technical approach and need specialized 
manufacture and quality control system.
2. It needs specialized magnet for targeting, for monitoring, and trained 
personnel to perform procedures.
3. Magnets must contain relatively constant gradients, to avoid focal 
over- dosing with toxic drugs.
4. A large fraction (40-60%) of the magnetite, which is entrapped in 
carriers, is deposited permanently in tissues.
Applications of magnetic microsphere






can be targeted to exact locations in the body through the application 
of	a	magnetic	field.
•	 The	magnetic	 localization	 of	 a	 therapeutic	 agent	 reducing	 or	
eliminating the systemic drug side effects.
•	 It	 is	used	 in	drug	 innovation,	molecular	 targeting,	DNA	analysis,	




Neutrophil Chemoattractant was first selected biomodulator for 
magnetic targeting due to its property when administered freely in 
circulation	 at	 a	 concentration	 beyond	 2×10−7M. It involves a site-
specific and local delivery to modulate inflammation and is a small, 
bacterially derived peptide, stable during microsphere preparation. It 
can be captured successfully in microparticles. The microsphere has 
been used either in disease modeling or clinical therapy.
In pulmonary medicine, these delivery systems are used as:
•	 An	 experimental	method	 to	 test	 novel	 agents	 so	 as	 to	 prevent	
neutrophil degradation of lung elastine in smokers.
•	 A	way	of	studying	the	involvement	of	acute	alveolar	damage	to	acute	
type respiratory distress syndrome.
•	 And	 as	 an	 adjuvant	method	 in	 treating	 invasive	 pulmonary	
aspergillosis suffering patients.
CONCLUSION
Over the years, magnetic microsphere has been investigated for targeted 
drug delivery especially magnetic targeted chemotherapy due to their 
better tumor targeting. Targeted drug delivery is an effective method to 
58
Asian J Pharm Clin Res, Vol 10, Issue 6, 2017, 54-58
 Sharma and Sharma 
assist the drug molecule to reach preferably to the desired site. It gives 
the idea that drugs reach the right site in the body, at the right time, at 
the right concentration. It does not exert side effects, neither on its way 
to the therapeutic target, not at the target site, nor during the clearance 
process. Thus, magnetic microspheres have the potential for these 
objectives. The main advantage of this technique is the reduction in the 
dose and side effects of the drug. The magnetic targeted chemotherapy 
has better tumor targeting, therapeutic efficacy, and lower toxicity. 
As the targeted drug delivery system implies selective and effective 
localization of drug into the target at therapeutic concentrations with 
limited access to non-target sites. Magnetic microspheres hold great 
promises for reaching the goal of controlled and site-specific drug 
delivery.
It is a demanding area for future research in the drug targeting so 
more researches, long-term toxicity study, and characterization 
determinations to give guarantee for the upgrading of magnetic 
drug delivery system. The future holds a lot of promises in magnetic 
microspheres, and by more study, this will be developed as novel and 
efficient approach for targeted drug delivery system.
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